Takeda's Partner Merges With Crestovo to Form Finch Therapeutics Group Post author:Sam Post published:October 22, 2017 Post category:BioPharma Two privately-held biotechs have merged to tackle recurrent C. difficile infections. Source: BioSpace You Might Also Like GlaxoSmithKline Ditches Ionis Pharma's Inotersen and IONIS-FB-LRx August 10, 2017 Busy Takeda Takes Out Tigenix in $630M Deal January 4, 2018 Bicycle Therapeutics Snags $52 Million to Take Early Stage Drugs Into Clinic May 31, 2017
